Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – MDCG 2023-7 Guidance on exemptions from the requirement to perform clinical investigations...

In the case of implantable devices and class III devices, clinical investigations shall be performed, except if: — the device has been designed by modifications of...
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) - updated information

Switzerland – New organisational structure with separate Medical Devices Surveillance Sector

For the strategy period 2023-2026, Swissmedic’s objectives include making legal responsibilities for medical devices more visible and stepping up international collaboration in this area....

UK – Heart vests to identify those at high risk of sudden cardiac death

In the UK, heart rhythms affect around two million people and can cause sudden death. A re-useable heart vest developed by researchers from University College...

UK- Wearable technology to be offered to thousands with type 1 diabetes in UK

The condition affects around 270,935 people in England and 16,090 people in Wales. The National Institute for Health and Care Excellence (NICE) has published final...

Europe – The clock is ticking – MedTech Europe’s recommendations ahead of May 2025...

Class D IVDs are critical for public health. They mainly fall into two categories: a) those related to blood, cells, tissues or organ screening,...

Europe – Questions & Answers for applicants, marketing authorisation holders of medicinal products and...

This Question and Answer (Q&A) document provides practical considerations concerning the implementation of the medical devices and the in vitro diagnostic medical devices regulations. This...
Opinion On Allergy Alert Test (AAT) as a proof-of-concept study

Europe – MDCG 2023-6 Guidance on demonstration of equivalence for Annex XVI products :...

The Regulation (EU) 2017/745 on medical devices, hereafter referred to as the MDR (medical device regulation), provides a possibility to use clinical data related...
Opinion On Allergy Alert Test (AAT) as a proof-of-concept study

Europe – MDCG 2023-5 – Guidance on qualification and classification of Annex XVI products...

The Regulation (EU) 2017/745 on medical devices, hereafter referred to as the MDR, is applicable to the groups of products without an intended medical...

Europe – Update – MDCG 2021-6 – Rev.1 – Regulation (EU) 2017/745 – Questions...

This document is intended for sponsors of clinical investigations of devices conducted within the scope of the Regulation (EU) 2017/745 (MDR). This document may be...

Europe – Designation of EU reference laboratories for high-risk in vitro diagnostic medical devices

On 5 December 2023, the European Commission adopted an implementing act designating 5 EU reference laboratories (EURLs) in the field of in vitro diagnostic medical devices...

NOS PROCHAINES FORMATIONS